Seven Bridges

company

About

Seven Bridges is the leading biomedical data science company.

Details

Last Funding Type
Series B
Last Funding Money Raised
$50M
Industries
Analytics,Bioinformatics,Clinical Trials,Cloud Data Services,Database,Health Care,Medical,Pharmaceutical,Professional Services
Founded date
Jan 1, 2009
Number Of Employee
101 - 250
Operating Status
Active
Legal Name
Seven Bridges Genomics, Inc.

Seven Bridges is the industry-leading infrastructure and data analytics company accelerating precision medicine by enabling the understanding of biomedical data. Our platform, services, and support expertise are driving discovery and drug development at the world’s leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaborations with the largest genomics projects, we connect the world’s biomedical information to enable the most efficient analysis at scale.

Named one of the world's smartest companies by MIT Technology Review, and a three-time Bio-IT World Best of Show winner, Seven Bridges has offices in Belgrade, Boston, Istanbul, and San Francisco.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$113M
Seven Bridges has raised a total of $113M in funding over 2 rounds. Their latest funding was raised on Apr 27, 2021 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 27, 2021 Series C $15M Detail
Apr 2, 2018 Series B $50M Detail
Feb 16, 2016 Series A $45M 1 Kryssen Capital Detail
Sep 1, 2014 Seed $3M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Seven Bridges is funded by 2 investors. Kryssen Capital and First Star Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Kryssen Capital Yes Series A
First Star Ventures Seed

Employee Profiles

Number of Employee Profiles
9
Seven Bridges has 9 current employee profiles, including Employee Bruce Press
Employee
Executive
Executive
Board member